Amakem

Kinase inhibitors developing therapeutics for the treatment of serious eye conditions.

placeAntwerp, Flanders, Belgium calendar_todayFounded 2010 groups23 employees language amakem.com

Innovation

15 patent families (6 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 377 times.

YearFilings
20123
20139
20146
20156
20164
20175
20181
20192
20201
20211
20221
20231

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Private equity240%
Coming soon